Further, our combined prognosis showed that the combined high expression of SP5, FOXP1, ROBO1, DPP4, CDYL2, and STAMBPL1 is associated to patients’ better clinical prognosis of patients with lung cancer (Fig. 3f). The gene discussed is SP5; the disease is lung cancer.